References
- Adashi, E. Y., and I. G. Cohen. 2015. “Editing the Genome of the Human Germline: May Cool Heads Prevail.” The American Journal of Bioethics 15 (12): 40–42. doi: https://doi.org/10.1080/15265161.2015.1103805
- ASGCT. 2017. Statement on DIY Gene Therapy. https://www.asgct.org/research/news/december-2017/asgct-statement-unregulated-diy-gene-therapy.
- Ball, P. 2017. “Designer Babies: An Ethical Horror Waiting to Happen?” The Observer, 8 January. Accessed 13 February 2017. https://www.theguardian.com/science/2017/jan/08/designer-babies-ethical-horror-waiting-to-happen.
- Baltimore, D., P. Berg, M. Botchan, D. Carroll, R. A. Charo, G. Church, E. C. Jacob, et al. 2015. “A Prudent Path Forward for Genomic Engineering and Germline Gene Modification.” Science 348 (6230): 36–38. doi: https://doi.org/10.1126/science.aab1028
- Baylis, F. 2017. “Human Nuclear Genome Transfer (So-Called Mitochondrial Replacement): Clearing the Underbrush.” Bioethics 31 (1): 7–19. doi: https://doi.org/10.1111/bioe.12309
- Bloomberg News. 2019. “China Proposes Stricter Rules on Gene Editing After Scandal.” 27 February 2019. Accessed 10 July 2019 https://www.bloomberg.com/news/articles/2019-02-27/china-proposes-stricter-rules-after-rogue-gene-scientist-scandal.
- Bonas, U., B. Friedrich, J. Fritsch, Albrecht Müller, Bettina Schöne-Seifert, Henning Steinicke, Klaus Tanner, et al. 2017. Ethical and Legal Assessment of Genome Editing in Research on Human Cells. https://www.leopoldina.org/uploads/tx_leopublication/2017_Diskussionspapier_GenomeEditing_01.pdf.
- Bud, R. 1993. The Uses of Life: A History of Biotechnology. Cambridge: Cambridge University Press.
- Burall, S. 2018. “Rethink Public Engagement for Gene Editing. Comment.” Nature 21: 438. https://www.nature.com/articles/d41586-018-03269-3. doi: https://doi.org/10.1038/d41586-018-03269-3
- BusinessWire. 2015. “Vertex and CRISPR Therapeutics Establish Collaboration to Use CRISPR-Cas9 Gene Editing Technology to Discover and Develop New Treatments for Genetic Diseases.” News release 26 October 2015. https://www.businesswire.com/news/home/20151026005392/en/Vertex-CRISPR-Therapeutics-Establish-Collaboration-CRISPR-Cas9-Gene.
- BVL. 2017. “Gentechnik mit Biologiebaukästen: Einfach, aber möglicherweise strafbar [Genetic Engineering with Biology Kits: Simple but Possibly Punishable].” Bundesamt für Verbraucherschutz und Lebensmittelsicherheit. https://www.bvl.bund.de/DE/06_Gentechnik/04_Fachmeldungen/2017/2017_01_25_DIY-Kits.html.
- Callaway, E. 2018. “CRISPR Plants Now Subject to Tough GM Laws in European Union.” Nature. News Story 25 July 2018 https://www.nature.com/articles/d41586-018-05814-6.
- Cameron, L., and R. Masten, eds. 2010. Metaphor Analysis: Research Practice in Applied Linguistics, Social Sciences and the Humanities. Sheffield: Equinox Publishing.
- Carey, N. 2019. Hacking the Code of Life: How Gene Editing Will Rewrite our Future. London: Icon Books.
- Christensen, C. 1997. The Innovator's Dilemma: When New Technologies Cause Great Firms to Fail. Boston, MA: Harvard Business School Press.
- Christensen, C. 2018. Disruptive Innovation. Web pages, Accessed 1 August 2018. http://www.claytonchristensen.com/key-concepts/.
- Cohen, J. 2017. “How the battle lines over CRISPR were drawn.” Science. 15 February 2017. https://www.sciencemag.org/news/2017/02/how-battle-lines-over-crispr-were-drawn.
- Council of Europe. 1997. “Convention on Human Rights and Biomedicine (Oviedo Convention).” ETS No. 164. Accessed 6 March 2018. https://www.coe.int/en/web/conventions/full-list/-/conventions/treaty/164.
- Cynober, T. 2019. “ CRISPR: One Patent To Rule them All.” LabtechEU. 11 February 2019. Accessed April 2019. https://labiotech.eu/features/crispr-patent-dispute-licensing/.
- Doudna, J. A., and S. H. Sternberg. 2017. A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution. New York: Houghton Mifflin Harcourt.
- European Union. 2000. Charter of Fundamental Rights of the European Union (2000/C 364/01).
- FDA. 2019. “FDA Announces April 25 Webinar on Genome Editing in Animals, Signalling Commitment to Implementing its Plant and Animal Biotechnology Innovation Action Plan.” 2 April 2019. https://www.lexology.com/library/detail.aspx?g=1a0db56b-04d9-4e0b-8662-18d0ef95e3e4.
- Franklin, S. 2006. “The Cyborg Embryo: Our Path to Transbiology.” Theory, Culture & Society 23 (7–8): 167–187. doi:10.1177/0263276406069230.
- Fuenfschilling, L., and B. Truffer. 2014. “The Structuration of Socio-Technical Regimes — Conceptual Foundations From Institutional Theory.” Research. Policy 43 (4): 772–791. doi: https://doi.org/10.1016/j.respol.2013.10.010
- Geels, F. W. 2018. “Disruption and low-Carbon System Transformation: Progress and New Challenges in Socio-Technical Transitions Research and the Multi-Level Perspective.” Energy Research & Social Science 37: 224–231. doi: https://doi.org/10.1016/j.erss.2017.10.010
- Isasi, R., E. Kleiderman, and E. B. M. Knoppers. 2016. “Editing Policy to Fit the Genome?” Science 351 (6271): 337–339. doi: https://doi.org/10.1126/science.aad6778
- Jasanoff, S., J. Hurlbut, and K. Saha. 2015. “Crispr Democracy: Gene Editing and the Need for Inclusive Deliberation.” Issues in Science and Technology 32 (1): 25–32.
- Keating, P., and A. Cambrosio. 2003. Biomedical Platforms: Realigning the Normal and the Pathological in Late-Twentieth-Century Medicine. Cambridge: MIT Press.
- King & Wood Mallesons. 2018. “United States Court of Appeals upholds PTAB Decision on CRISPR Patent Interference.” Lexology, 24 September, 2018. Accessed 25 April 2019. https://www.lexology.com/library/detail.aspx?g=e28a705f-30f6-4208-87fc-afd8544ee633.
- Kirkpatrick, J., Gregory D. Koblentz, Megan J. Palmer, Edward Perello, David A. Relman, Sarah W. Denton. 2018. Editing Biosecurity: Needs and Strategies for Governing Genome Editing. Institute for Philosophy and Public Policy, George Mason University. http://mars.gmu.edu/bitstream/handle/1920/11342/Editing-Bio-%2bReport-Final.pdf?sequence=1&isAllowed=y.
- Knoppers, B. M., R. Isasi, T. Caulfield, E. Kleiderman, P. Bedford, J. Illes, U. Ogbogu, V. Ravitsky, and M. Rudnicki. 2017. “Human Gene Editing: Revisiting Canadian Policy.” Regenerative Medicine 2 (3): 1–3.
- Koo, T., J. Lee, and J. S. Kim. 2015. “Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9.” Molecules and Cells 38 (6): 475–481. doi:10.14348/molcells.2015.0103.
- Kozubek, J. 2016. Modern Prometheus: Editing the Human Genome with Crispr-Cas9. Cambridge: Cambridge University Press.
- Kuiken, T. 10 March 2016. “Learn from DIY Biologists.” Nature 531: 167–168. doi: https://doi.org/10.1038/531167a
- Landecker, H. 2007. Culturing Life: How Cells Became Technologies. Cambridge, MA: Harvard University Press.
- Lander, E. S. 2015. “Brave New Genome.” The New England Journal of Medicine 373: 5–8. doi: https://doi.org/10.1056/NEJMp1506446
- Ledford, H. 4 June 2015. “CRISPR the Disrupter.” Nature 522: 20–24. doi: https://doi.org/10.1038/522020a
- Lovell-Badge, Robin. 2019. “CRISPR Babies: A View from the Centre of the Storm.” Development 146: 1–5. doi:10.1242/dev.175778.
- Marvin, C. 1990. When Old Technologies Were New: Thinking About Electric Communication in the Late Nineteenth Century. Oxford: Oxford University Press.
- McKie, R. 2018. “US Gene-Editing Ruling Delights Plant Scientists.” The Observer. 8 April 2018. Accessed 2 May 2018. https://www.theguardian.com/science/2018/apr/07/gene-editing-ruling-crops-plants.
- McLeod, C., and B. Nerlich. 2017. “Synthetic Biology, Metaphors and Responsibility.” Life Sciences, Society and Policy 13 (13). https://lsspjournal.springeropen.com/articles/10.1186/s40504-017-0061-y.
- McMahon, A. 2019. “0Patents as Private Governance Tools.” Working paper, 2019.
- Morrison, M. 2012. “Promissory Futures and Possible Pasts: They Dynamics of Contemporary Expectations in Regenerative Medicine.” BioSocieties 7: 2–22. doi: https://doi.org/10.1057/biosoc.2011.24
- Morrison, M., M. Mourby, A. Bartlett, and E. Bicudo. 2019. “Mapping the Biomodifying Technology Landscape.” Impact 1: 63–65. doi: https://doi.org/10.21820/23987073.2019.1.63
- Mudziwapasi, R., A. Ndudzo, R. P. Nyamusamba, F. N. Jomane, T. T. Mutengwa, M. Maphosa. 2018. “Unlocking the Potential of CRISPR Technology for Improving Livelihoods in Africa.” Biotechnology and Genetic Engineering Reviews. doi:10.1080/02648725.2018.1482101.
- NAS. 2017. “Human Genome Editing: Science, Ethics and Governance.” http://www.nationalacademies.org/gene-editing/consensus-study/index.htm.
- Nerlich, B. 2019. “Crispr Culture”. Blog post on the Making Science Public Blog. Accessed 12 March 2019. http://blogs.nottingham.ac.uk/makingsciencepublic/2019/03/15/crispr-culture.
- Nuffield Council on Bioethics. 2018. Genome Editing and Human Reproduction: Social and Ethical Issues. London: Nuffield Council. http://nuffieldbioethics.org/project/genome-editing-human-reproduction.
- O'Keefe, M., S. Perrault, J. Halpern, L. Ikemoto, M. Yarborough, and UC North Bioethics Collaboratory for Life & Health Sciences. 2015. “Editing’ Genes: A Case Study About how Language Matters in Bioethics.” The American Journal of Bioethics 15 (12): 3–10. doi: https://doi.org/10.1080/15265161.2015.1103804
- Parliamentary Office of Science and Technology (POST). 2016. Genome Editing. Houses of Parliament POST Note 541.
- Pierson, B. 2019. “University of California to be Granted Pioneering CRISPR Patent.” Reuters, 8 February 2019. Accessed 25 April 2019. https://www.reuters.com/article/us-ucberkeley-ip-crispr/university-of-california-to-be-granted-pioneering-crispr-patent-idUSKCN1PX25K.
- Reardon, J. 2017. The Postgenomic Condition: Ethics, Justice, and Knowledge After the Genome. Chicago: The University of Chicago Press.
- Reardon, S. 2015. “Global Summit Reveals Divergent Views on Human Gene Editing.” Nature 528 (7581): 173. doi:10.1038/528173a.
- Reuters. 2018. “Sangamo in $3 Billion Gene-Editing Deal with Gilead.” News release 22 February 2018. https://uk.reuters.com/article/uk-sangamo-deals-gilead-sciences/sangamo-in-3-billion-gene-editing-deal-with-gilead-idUKKCN1G61I4.
- Rosemann, A., A. Balen, B. Nerlich, C. Hauskeller, M. Sleeboom-Faulkner, S. Hartley, X. Zhang, and N. Lee. 2019. “Heritable Genome Editing in a Global Context: National and International Policy Challenges.” The Hastings Center Report 49 (3): 30–42. doi: https://doi.org/10.1002/hast.1006
- Royal Society. 2018. Genetic Technologies. Accessed 8 March 2018. https://royalsociety.org/topics-policy/projects/genetic-technologies/.
- SAM. 2017. New Techniques in Agricultural Biotechnology. High Level Group of Scientific Advisors, Explanatory Note 02. Scientific Advice Mechanism (SAM). Brussels: EU Directorate-General for Research and Innovation.
- San Martín, B., and H. Smith-Willis. 2015. “Revolutionising Genome Editing with CRISPR/Cas9: Patent Battles and Human Embryos.” Cell Gene Therapy Insights 1 (2): 253–262.
- Sarewitz, D. 2015. “CRISPR: Science Can’t Solve it.” Nature 522 (7557): 413–414. doi: https://doi.org/10.1038/522413a
- Scheufele, D. A., M. A. Xenos, E. L. Howell, K. M. Rose, D. Brossard, and B. W. Hardy. 2017. “US Attitudes on Human Genome Editing.” Science 357 (6351): 553–555. doi: https://doi.org/10.1126/science.aan3708
- Sherkow, J. 2017. “Patent Protection for CRISPR: An ELSI Review.” Journal of Law and the Biosciences 4 (3): 565–576. doi: https://doi.org/10.1093/jlb/lsx036
- Taconic. 2018. Application of CRISPR/Cas to the Generation of Genetically Engineered Mice. Taconic Inc. www.taconic.com.
- Thompson, C. 2013. Good Science: The Ethical Choreography of Stem Cell Research. Cambridge: MIT Press.
- Turkmendag, I. 2017. “It Is Just a “Battery”: “Right” to Know in Mitochondrial Replacement.” Science, Technology and Human Values 43 (1): 56–85. doi: https://doi.org/10.1177/0162243917722843
- UNESCO. 1997. “Universal Declaration on the Human Genome and Human Rights 1997 (UNESCO)”.
- UNESCO. 2015. “Report of the IBC on Updating Its Reflection on the Human Genome and Human Rights.” http://unesdoc.unesco.org/images/0023/002332/233258e.pdf.
- Weisman, R. 2016. “CRISPR Takes the Wraps off Joint Venture with Bayer.” The Boston Globe. 19 August.
- Winskel, M. 2018. “Beyond the Disruption Narrative: Varieties and Ambiguities of Energy System Change.” Energy Research & Social Science 37: 232–237. doi: https://doi.org/10.1016/j.erss.2017.10.046
- Zhai, X., R. Lei, W. Zhu, and R. Qiu. 2019. “Chinese Bioethicists Respond to the Case of He Jiankui.” The Hastings Centre. Accessed 5 April 2019. https://www.thehastingscenter.org/chinese-bioethicists-respond-case-jiankui/.